Literature DB >> 6325138

Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor (GRF).

N Miki, M Ono, K Shizume.   

Abstract

An antiserum raised against human pancreatic growth hormone-releasing factor-(1-40) (hpGRF-40) was found to recognize the rat hypothalamic growth hormone-releasing factor (rhGRF): This antiserum, when given iv to adult male rats, completely abolished GH release induced by a synthetic rhGRF (0.2, 1 microgram/kg BW), and inhibited the physiological GH secretion over 2 days. After passive immunization with anti-hpGRF-40 serum, iv injection of either FK 33-824 (100 micrograms/kg BW), an enkephalin analogue, or clonidine (125 micrograms/kg BW), an alpha-adrenergic agent, failed to stimulate GH release in the unanesthetized rat. These results indicate that the GH-releasing actions of opiatergic and alpha-adrenergic mechanisms are mediated through stimulation of endogenous rhGRF release in the rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325138     DOI: 10.1210/endo-114-5-1950

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Growth hormone--a cogonadotropin? Its role in ovulation induction.

Authors:  Z Blumenfeld
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

Review 2.  The neuroendocrine approach to psychiatric disorders: a critical appraisal.

Authors:  E E Müller
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 3.  Clonidine treatment in children with short stature.

Authors:  S Loche; A Lampis; S G Cella; V Locatelli; E E Müller; C Pintor
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

4.  Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by D-Met2,Pro5-enkephalinamide in man.

Authors:  J Földes; A Váradi; A Gara; C Bános; P Vargha; K Török; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 5.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

Review 6.  Regulation of growth hormone secretion in man: a review.

Authors:  D G Johnston; R R Davies; R W Prescott
Journal:  J R Soc Med       Date:  1985-04       Impact factor: 5.344

7.  Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man.

Authors:  Vittorio Coiro; Riccardo Volpi; Adriano Stella; Simona Cataldo; Claudio Giumelli; Francesco Maccanelli; Anna Araldi; Paolo Chiodera
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

8.  Serotonergic influence on the growth hormone response to clonidine in rat.

Authors:  B Söderpalm; L Andersson; M Carlsson; K Modigh; E Eriksson
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

9.  Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine.

Authors:  F Orio; N Padovano; L Cinquanta; A Colao; B Merola; S Longobardi; E Rossi; V Esposito; F Orio; G Lombardi
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

Review 10.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.